When China recently lifted its longtime ban on video-game consoles, it opened a hungry market for manufacturers such as Sony, Microsoft and Nintendo. The ban – in place since 2000 – prevented gaming companies from marketing to the most populous nation on Earth because Chinese officials were concerned about the violent content of some games, […]
By offering 100% original and unmatched content by the best financial reporters, writers and bloggers in the business, EmergingGrowth.com is emerging as a leading digital financial media portal. Its services provide users, subscribers and advertisers with a variety of content and tools through a range of online, social media, mobile and other mobile outlets.
Our mission is to attribute the most recent global events related to the financial markets, the economy, and industry trends, to the equities that will be affected by them and provide our users sound data with which they can make educated investment decisions. EmergingGrowth.com breaks down the barriers between current events and the financial markets leaving investors with a clear view of the road ahead.
We level the playing field and help all individuals and organizations grow their wealth by offering ideas on Emerging Growth companies found nowhere else. The smaller companies that make the big ones bigger, have potentially more room to grow. That is where we focus our attention and it is reflected in our stories. We offer the most comprehensive tools and insight needed to make informed investment decisions.
Since its inception, EmergingGrowth.com has distinguished itself from other financial media companies with its sly approach to reading between the lines in order to locate that needle in the haystack. Subscribe today to see what EmergingGrowth.com has to offer.
More from Emerging Growth
I just saw this commercial on youtube. I thought it would be nice to post for my tech followers. I’ve got serious concerns about innovation and more importantly strategic partners with apple.
It’s been a while since the last article in the dividend investing series, but we’re back with this series and hope to make it more frequent. In this edition, we’ll examine a small-cap dividend stock that you can consider for a dividend reinvestment plan, or DRIP for short. Before we discuss the company in question, […]
Many biotech players have slated 2014 as the year to accomplish goals, ranging from announcement of results from clinical trials to submitting their drug candidates to the FDA for review and possible approval. These sorts of developments will give investors an idea regarding the direction biotech companies are headed. Therefore, I thought I should bring […]
As we wave goodbye to a glorious 2013 for the stock market and welcome the New Year, many investors are gathering their New Year investment goals and trying to determine this year’s top sectors and stocks. Aside from the stock market, we saw oil prices gain only 7 percent on the year, while the S&P […]
Digimarc Corp. (NASDAQ: DMRC) recently announced a simplified pricing model. Its web-based service platform, Digimarc Discover Online Services will provide a simple sign-up and purchase process that will reward frequent users with volume discounts. Under the new system, customers will be able to achieve lower pricing levels once they have reached a certain level of […]
If you’re an avid follower of investment guru Warren Buffet, you’ll probably have heard this quote: “The 19th century belonged to England, the 20th century belonged to the U.S., and the 21st century belongs to China. Invest accordingly.” As such, whenever value investors come across publicly traded (U.S. traded especially) Chinese companies, it could be […]
Over two weeks into 2014, the market appears to be correcting as investors lock in profits from an outstanding 2013 market. It is still too early to tell if we are beginning a significant correction and, as I have said in previous articles, gaining a buying opportunity or dollar cost averaging. As we wait for […]
Like many small-cap biotech companies, Cempra, Inc. (NASDAQ: CEMP) is a clinical stage company with its focus set on developing antibiotics to treat drug-resistant bacterial infections. First thing to note is that this company is in a somewhat difficult business. Developing treatments for infections that aren’t drug-resistant is difficult. If this company has the right […]
Another milestone happened for Vical Incorporated (NASDAQ: VICL) this month. A few weeks ago, it disclosed to the public the beginning of its Phase ½ trial of Vaxfectin, a formulated therapeutic vaccine for herpes simplex virus (HSV-2). The trial will allow the company to pursue more studies to minimize the rate of HSV-2 in individuals […]
By, Lennox Yieke Citing a recent cabinet report, Xinhua, the Chinese state-run news agency, called for 7.6 percent growth for the Chinese economy in 2013. While actual figures will be officially released late January, various reputable research firms have placed their growth estimates within the same range. If China has grown 7.6 percent in 2013, […]
Ceragon Network (NASDAQ: CRNT) announced a couple of months that it has received additional orders of $7 million from Vodacom Tanzania, the largest mobile operator in the country. The upgrade will address the increased continued growth, as well as continued demand in advanced data services. Vodacom Tanzania is a subsidiary of the Vodacom Group Ltd. […]
Electronics platform firm CUI Global (NASDAQ: CUI) recently announced to the public it was commissioned by an undisclosed Norweigan liquid natural gas processing facility, through its subsidiary Orbital Gas Systems Inc., for three sampling systems using its proprietary VE Technology from The Linde Group. The initial order has an estimated value of $410,000. These units […]